Jun 2, 2026 09:06AM
Jun 2, 2026 09:06AM
May 21, 2026 05:00PM
May 21, 2026 05:00PM
May 14, 2026 04:10PM
Apr 21, 2026 10:00AM
Apr 21, 2026 10:00AM Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
Apr 17, 2026 04:01PM
Apr 17, 2026 04:01PM
Apr 9, 2026 04:01PM
Apr 9, 2026 04:01PM
Mar 26, 2026 06:49AM
Feb 24, 2026 04:30PM
Jan 28, 2026 06:45AM H.C. Wainwright Reiterates Buy Rating on Cardiff Oncology (CRDF)
Jan 27, 2026 07:05AM
Jan 27, 2026 07:05AM
Jan 27, 2026 07:00AM
Jan 27, 2026 07:00AM
Dec 21, 2025 04:00AM
Dec 12, 2025 10:31AM
Dec 8, 2025 04:06PM Cardiff Oncology presents leukemia trial data at ASH 2025
Dec 8, 2025 04:05PM
Nov 6, 2025 04:05PM
Jul 29, 2025 04:07PM
Jul 29, 2025 04:07PM
Jul 29, 2025 04:05PM
Jul 8, 2025 08:50AM
Jun 17, 2025 04:05PM Cardiff Oncology (CRDF) Appoints Roger Sidhu as Chief Medical Officer, Announces Timing for the Next Update from the CRDF-004 Trial
Jun 17, 2025 04:05PM
Jun 2, 2025 04:06PM
Jun 2, 2025 04:05PM
May 8, 2025 04:05PM
Apr 23, 2025 04:09PM
Apr 23, 2025 04:05PM
Apr 15, 2025 04:05PM Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
Apr 14, 2025 06:41AM
Feb 27, 2025 04:05PM
Jan 2, 2025 12:51PM
Dec 26, 2024 09:00AM
Dec 10, 2024 07:21AM
Dec 10, 2024 07:20AM
Dec 10, 2024 07:12AM Cardiff Oncology (CRDF) Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial
Dec 10, 2024 06:00AM
Nov 19, 2024 08:04AM
Nov 19, 2024 08:00AM
Nov 7, 2024 04:05PM
Oct 30, 2024 04:30PM
Aug 8, 2024 04:05PM
May 2, 2024 04:05PM Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
Feb 29, 2024 04:20PM

322,086 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All